These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17985999)

  • 1. Biologic aspects of thrombopoietin and the development of novel thrombopoietic agents for clinical use.
    Evangelista ML; Amadori S; Stasi R
    Curr Drug Discov Technol; 2007 Oct; 4(3):162-73. PubMed ID: 17985999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietic agents.
    Stasi R; Bosworth J; Rhodes E; Shannon MS; Willis F; Gordon-Smith EC
    Blood Rev; 2010; 24(4-5):179-90. PubMed ID: 20493600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of novel thrombopoietic agents in the management of acute leukemia?
    Kuter DJ
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):372-378. PubMed ID: 27890262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New thrombopoietic growth factors.
    Kuter DJ
    Blood; 2007 Jun; 109(11):4607-16. PubMed ID: 17289815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical findings with the first generation of thrombopoietic agents.
    Vadhan-Raj S
    Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
    Kuter DJ
    Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of thrombopoietin and thrombopoietin receptor agonists.
    Kuter DJ
    Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New thrombopoietic growth factors.
    Kuter DJ
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S347-56. PubMed ID: 19778863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
    Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New thrombopoietin receptor agonists for platelet disorders.
    Homeida S; Ebdon C; Batty P; Jackson B; Kolade S; Bateman C; Peng YY; Stasi R
    Drugs Today (Barc); 2012 Apr; 48(4):293-301. PubMed ID: 22536571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and chemistry of thrombopoietic agents.
    Kuter DJ
    Semin Hematol; 2010 Jul; 47(3):243-8. PubMed ID: 20620435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin factors.
    Wei P
    Cancer Treat Res; 2011; 157():75-93. PubMed ID: 21052951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology and clinical application of thrombopoietin receptor agonists.
    Li C; Zheng L
    Int J Hematol; 2014 Dec; 100(6):529-39. PubMed ID: 25230815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romiplostim: a second-generation thrombopoietin agonist.
    Cohn CS; Bussel JB
    Drugs Today (Barc); 2009 Mar; 45(3):175-88. PubMed ID: 19436840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T; Imbach P
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milestones in understanding platelet production: a historical overview.
    Kuter DJ
    Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic aspects of thrombopoietins and the development of therapeutic agents.
    Solberg LA
    Curr Hematol Rep; 2005 Nov; 4(6):423-8. PubMed ID: 16232377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Rodeghiero F; Carli G
    Ann Hematol; 2017 Sep; 96(9):1421-1434. PubMed ID: 28275823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia.
    Kuter DJ
    Annu Rev Med; 2009; 60():193-206. PubMed ID: 19642221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.